Screener
Vir Biotechnology, Inc. VIR Payroll and related expenses
Payroll and related expenses at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept vir:AccruedPayrollAndRelatedExpenseCurrent.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Research and development expenses | $35,465 | $35,299 |
| Payroll and related expenses | 13,957 | 28,724 |
| Excess funds payable under grant agreements | 1,832 | 1,825 |
| Operating lease liabilities, current | 9,137 | 8,798 |
| Other professional and consulting expenses | 9,009 | 3,327 |
| Other accrued expenses | 7,807 | 5,039 |
| Total accrued and other liabilities | $77,207 | $83,012 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Vir Biotechnology, Inc.'s payroll and related expenses?
- Vir Biotechnology, Inc. (VIR) reported payroll and related expenses of $13.96M in Q2 2026.
- How has Vir Biotechnology, Inc.'s payroll and related expenses changed year-over-year?
- Vir Biotechnology, Inc.'s payroll and related expenses decreased by 19.9% year-over-year, from $17.41M to $13.96M.
- What does payroll and related expenses mean?
- Payroll and related expenses as reported by Vir Biotechnology, Inc. Common Stock.
Ask your AI about Vir Biotechnology, Inc.'s payroll and related expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude